Skip to main content
Judith Currier, MD, Infectious Disease, Los Angeles, CA

JudithSilversteinCurrierMD

Infectious Disease • Los Angeles, CA

HIV/AIDS Medicine

Professor of Medicine, UCLA-David Geffen School of Medicine

Join to view full profile

Dr. Currier is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Currier's full profile

Already have an account?

Summary

  • Dr. Judith Currier is Professor of Medicine and Chief of the Division of Infectious Diseases at the David Geffen School of Medicine at UCLA. She serves as Chair of the AIDS Clinical Trials Network, a global group of investigators focused on improving treatment for HIV and related co-infections. She received her medical degree from Geisel School of Medicine at Dartmouth and completed training in Infectious Diseases and Epidemiology and has been in practice 32 years. She specializes in HIV medicine and is the Co-Director of the UCLA Center for Clinical AIDS Research and Education.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1988 - 1991
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - 2024
  • GA State Medical License
    GA State Medical License Active through 2013
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Top Doctors:LA Area Castle Connolly, 2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Safety and Impact of Low-Dose Methotrexate on Endothelial Function and Inflammation in Individuals with Treated Human Immunodeficiency Virus: AIDS Clinical Trials Grou...  
    Steven G Deeks, James H Stein, Carl Fichtenbaum, Judith S Currier, Priscilla Y Hsue, Eric S Daar, Ahmed Tawakol, Michael Lederman, Tanvir Bell, Diane Havlir, Clinical Infectious Diseases
  • Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large HIV Treatment-Naive Clinical Trial  
    Raphael J Landovitz, Judith S Currier, Clinical Infectious Diseases
  • Lower Pretreatment Gut Integrity Is Independently Associated with Fat Gain on Antiretroviral Therapy  
    Judith S Currier, Peter W Hunt, Clinical Infectious Diseases

Other

Press Mentions

  • ACTG Announces Publication of Pivotal Hepatitis C Study in Clinical Infectious Diseases
    ACTG Announces Publication of Pivotal Hepatitis C Study in Clinical Infectious DiseasesMarch 21st, 2023
  • UC San Diego Participates in National Trial to Assess Potential Treatment for Human Monkeypox
    UC San Diego Participates in National Trial to Assess Potential Treatment for Human MonkeypoxOctober 27th, 2022
  • ACTG Presents Data Showing Success of Hepatitis B Vaccine Among People Living with HIV at IDWeek 2022
    ACTG Presents Data Showing Success of Hepatitis B Vaccine Among People Living with HIV at IDWeek 2022October 20th, 2022
  • Join now to see all

Grant Support

  • Optimizing Antiretroviral Therapy In HIVNational Institute Of Allergy And Infectious Diseases2009–2012
  • Clinical Research Facilitation CoreNational Institute Of Allergy And Infectious Diseases2008–2012
  • UCLA AIDS Prevention And Treatment Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
  • Prospective Evaluation Of Antiviral Therapy And Cardiac HealthNational Heart, Lung, And Blood Institute2008–2011
  • Phase II, Randomized, Double-Blind Study Of The Safety And Efficacy Of SCH 41National Center For Research Resources2006–2010
  • A Phase IV, Prospective, Randomized, Open-Label Evaluation Of The Efficacy OfNational Center For Research Resources2006–2010
  • A Phase Ii/Iii, Randomized, Double-Blind, Placebo-Controlled Trial Of UridineNational Center For Research Resources2007–2009
  • Sex Differences In Pharmacokinetics Of Lopinavir/Ritonavir Among HIV-1 InfectNational Center For Research Resources2007–2008
  • A Pilot Study Of The Safety, Efficacy, And Tolerability Of Ezetimibe (Zetia?)National Center For Research Resources2007–2008
  • Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients ReceivinNational Center For Research Resources2006–2008
  • Fat Redistribution And Metabolic Change In HIV Infection: Protocol 2 (Fram 2)National Center For Research Resources2006–2007
  • Metabolic Complication Of HIV InfectionNational Institute Of Allergy And Infectious Diseases2003–2007
  • Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (AllrNational Center For Research Resources2005–2006
  • A Prospective Observational Study Of Virologic And Immunologic Changes In HIVNational Center For Research Resources2005–2006
  • AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2004–2006
  • STD Faculty Expansion ProgramNational Center For Hiv, Viral Hepatitis, Stds And Tb Prevention2003–2006
  • Stavudine Drugs &Risk Metabolic Toxicity: PATS Recv Antiretroviral Therapy:AidsNational Center For Research Resources2005
  • A Study Investigating Plasma Levels Of D-Chiro-Inositol In Patients With HIVNational Center For Research Resources2005
  • A Randomized, Double-Blind, Placebo-Controlled Study Of Metformin And RosigliNational Center For Research Resources2005
  • A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Of Once-WeeklyNational Center For Research Resources2005
  • Study Investigating Plasma Levels Of D-Chiro-InositolNational Center For Research Resources2004
  • Stavudine Drug Levels And The Risk Of Metabolic Toxicity In Patients Receivin...National Center For Research Resources2004
  • Randomized, Double-Blind, Placebo-Controlled Study OfNational Center For Research Resources2004
  • Pilot Study Of The Safety, Efficacy, And TolerabilityNational Center For Research Resources2004
  • Phase II, Randomized, Double-Blind, Placebo-ControlledNational Center For Research Resources2004
  • Adults AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (Allr...National Center For Research Resources2004
  • Viracept (BID) And Sanquinavir (BID) Compared With Tid Dosing In HIVNational Center For Research Resources1999–2002
  • Actg365--Steady State PK Interaction Study Of Indinavir &RifabutinNational Center For Research Resources1999–2002
  • 24 Week Study Of Indinavir Sulfate 800 MG Q8h Versus 1200 MG Q12hNational Center For Research Resources1999–2002
  • Phase I/II Trial Of Nandrolone Decanoate In Women W/ HIV Associated Weight LossNational Center For Research Resources1998–2002
  • Phase II, Randomized Trial Of Amprenavir As PART Of Dual Protease InhibitorNational Center For Research Resources1999–2001
  • Phase II, Randomized Study Of The Safety And Efficacy Of ViraceptNational Center For Research Resources1998–1999

Dr. Judith Currier, Dr. Judith Currier, MD, Dr. J Currier, Dr. Judith Silverstein Currier